Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.44 USD | -0.85% | +2.86% | -11.90% |
Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Apr. 09 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Evolution of the average Target Price on Alkermes plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Alkermes plc
Baird | |
UBS | |
Piper Sandler | |
Evercore ISI | |
Mizuho Securities | |
Stifel Nicolaus | |
HC Wainwright | |
JPMorgan Chase | |
BofA Securities | |
SVB Leerink | |
Goldman Sachs | |
Citigroup | |
Cantor Fitzgerald |
EPS Revisions
- Stock Market
- Equities
- ALKS Stock
- Consensus Alkermes plc